Orion Pharma Limited announces unaudited consolidated earnings results for the second quarter and six months ended December 31, 2016. For the second quarter, the company's EPS was BDT 1.29 per share against BDT 1.27 per share for the same period last year. For the six months, the company's EPS was BDT 2.46 per share against BDT 2.00 per share for the same period last year. NOCFPS was BDT 3.22 against BDT 4.71 per share for the same period last year.